基金大事件|首批10只科创债ETF集体上市！

Group 1: Fund Manager Dynamics - In Q2 2023, many high-performing funds maintained high positions, focusing on increasing investments in technology and pharmaceutical sectors, with fund managers optimistic about the value of equity assets and structural opportunities [3] - The first batch of 10 Sci-Tech Bond ETFs, attracting nearly 30 billion yuan in investments, will be listed on July 17, providing investors with efficient tools for participating in the Sci-Tech bond market [3] - On July 17, A-share market saw a net inflow of 1.891 billion yuan into industry-themed ETFs, with securities, low-volatility dividends, and photovoltaic ETFs being the main beneficiaries [6] Group 2: Fund Performance and Changes - Two new funds in the innovative drug sector have seen their net asset values double, with year-to-date increases exceeding 100%, indicating a strong outlook for the innovative drug sector [10] - As of July 11, over 1,970 funds have experienced changes in fund manager positions this year, with more than 700 funds adopting a "co-management" model to enhance management efficiency and reduce reliance on star fund managers [8] - On July 19, a significant change in leadership occurred at Fidelity Fund, with a new chairman appointed, reflecting ongoing shifts in fund management [9] Group 3: REITs and Fundraising - On July 16, two public REITs raised over 470 billion yuan in a single day, with both funds achieving full subscription on the first day of their offering [14] - The announcement of the new chairman at Huatai Fund on July 14 indicates a strategic shift within the company, as the previous chairman continues to serve in other capacities [15] Group 4: Industry Movements - A notable trend of high-profile professionals transitioning from public to private fund management is emerging, with a prominent quantitative analyst announcing the establishment of a private fund management company [17][18] - The private equity sector mourned the loss of a well-known research director, highlighting the human aspect of the industry [19]